OIS at AAO 2015

Aerie Pharmaceuticals

Nov 12, 2015 4:00pm ‐ Nov 12, 2015 4:10pm


Description

We are a publicly traded, clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Glaucoma is one of the largest segments in the global ophthalmic market.

Speaker(s):

You must be logged in and own this session in order to post comments.